Myelomacrowd.org

Myeloma Crowd. Patient stories, Multiple Myeloma basics articles, and clinical trial updates with new content every week.

What’s new on Myelomacrowd.org: Check updates and related news right now. This site’s feed is stale or rarely updated (or it might be broken for a reason), but you may check related news or Myelomacrowd.org popular pages instead. It is generally safe for browsing, so you may click any item to proceed to the site.

News, stories and media buzz related to Myeloma Crowd

Subscribe to related news

Strategies to Improve Treatment
via news.cancerconnect

The development of more effective treatment for multiple myeloma requires that new and innovative therapies be evaluated with cancer patients. Future progress in the treatment of multiple myeloma will result from the continued evaluation of new treatments...
CURE Media Group Names Inaugural Group of Multiple Myeloma Heroes
via pressreleaserocket

Award Honors Individuals Making a Difference in Multiple Myeloma PLAINSBORO, N.J. (PRWEB) March 19, 2016 CURE Media Group, the nation’s leading digital and print media enterprise focused on cancer patients, today officially named eight recipients of...
U.S. FDA Approves Takeda’s NINLARO® (ixazomib), the First and Only Oral Proteasome Inhibitor to Treat Multiple Myeloma
via news-pr

Business Wire India Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the U.S. Food and Drug Administration (FDA) has approved NINLARO® (ixazomib) capsules, the first and only oral proteasome inhibitor, indicated in combination...
Centers for Disease Control and Prevention (CDC) Healthcare News Update ► DLS|HEALTHCARE NEWS|August 13, 2015
via elbiruniblogspotcom.blogspot

DLS|HEALTHCARE NEWS|August 13, 2015 A Weekly Compilation of Clinical Laboratory and Related Information From The Division Of Laboratory Systems August 13, 2015 News Highlights Leading News Ebola Survivors Face Lingering Pain, Fatigue, and Depression...
Daratumumab (DARZALEX®) Combination Therapy Significantly Extended Progression-Free Survival in Previously Treated Patie...
via military-technologies

CHICAGO and RARITAN, N.J., June 5, 2016 /PRNewswire/ -- Data from the Phase 3 MMY3004 (CASTOR) clinical trial show the immunotherapy daratumumab (DARZALEX®) in combination with a standard of care therapy, bortezomib (a proteasome inhibitor [PI]) and...

Myelomacrowd.org popular pages

MCTV Archives - The Myeloma Crowd

Type Text Here Myeloma Patient Facebook Groups
Affording Multiple Myeloma - The Myeloma Crowd

Tweet BY YOLANDA BRUNSON-SARRABO Sometimes patients can feel like cancer opens the doors for pharmaceutical industries to not only treat these diseases and help extend life, but make a lot of money in...

Multiple Myeloma News - HealthTree Myeloma

HealthTree News for Multiple Myeloma site features news articles, patient stories, Multiple Myeloma basics articles, and clinical trial updates with new content every week.